{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T22:10:58Z","timestamp":1790287858740,"version":"4.1.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aaojournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1016\/j.ophtha.2011.11.032","type":"journal-article","created":{"date-parts":[[2012,2,23]],"date-time":"2012-02-23T10:16:22Z","timestamp":1329992182000},"page":"1250-1257","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":248,"title":["Ganglion Cell Loss in Relation to Visual Disability in Multiple Sclerosis"],"prefix":"10.1016","volume":"119","author":[{"given":"Scott D.","family":"Walter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin M.","family":"Galetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reiko E.","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"Feller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam B.","family":"Henderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maureen G.","family":"Maguire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven L.","family":"Galetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elliot","family":"Frohman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter A.","family":"Calabresi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel S.","family":"Schuman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura J.","family":"Balcer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ophtha.2011.11.032_bib1","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s13311-010-0005-1","article-title":"Optical coherence tomography (OCT): imaging the visual pathway as a model for neurodegeneration","volume":"8","author":"Galetta","year":"2011","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.ophtha.2011.11.032_bib2","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1177\/1352458510371640","article-title":"Reproducibility of high-resolution optical coherence tomography in multiple sclerosis","volume":"16","author":"Syc","year":"2010","journal-title":"Mult Scler"},{"key":"10.1016\/j.ophtha.2011.11.032_bib3","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1001\/archneur.65.9.1218","article-title":"Reproducibility of optical coherence tomography in multiple sclerosis","volume":"65","author":"Cettomai","year":"2008","journal-title":"Arch Neurol"},{"key":"10.1016\/j.ophtha.2011.11.032_bib4","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1097\/WNO.0b013e3181facbbd","article-title":"Comparison of retinal nerve fiber layer and central macular thickness measurements among five different optical coherence tomography instruments in patients with multiple sclerosis and optic neuritis","volume":"31","author":"Watson","year":"2011","journal-title":"J Neuroophthalmol"},{"key":"10.1016\/j.ophtha.2011.11.032_bib5","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1111\/j.1755-3768.2010.02045.x","article-title":"Intra and interoperator reproducibility of retinal nerve fibre and macular thickness measurements using Cirrus Fourier-domain OCT [report online]","volume":"89","author":"Garcia-Martin","year":"2011","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.ophtha.2011.11.032_bib6","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/IAE.0b013e3181bd2c3b","article-title":"Comparison of spectral\/Fourier domain optical coherence tomography instruments for assessment of normal macular thickness","volume":"30","author":"Sull","year":"2010","journal-title":"Retina"},{"key":"10.1016\/j.ophtha.2011.11.032_bib7","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1136\/bjo.2010.196907","article-title":"Retinal nerve fibre layer and visual function loss in glaucoma: the tipping point","volume":"96","author":"Wollstein","year":"2012","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2011.11.032_bib8","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/S1474-4422(10)70168-X","article-title":"Optical coherence tomography in multiple sclerosis: a systematic review and meta-analysis","volume":"9","author":"Petzold","year":"2010","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.ophtha.2011.11.032_bib9","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/nrneurol.2009.41","article-title":"Imaging outcomes for neuroprotection and repair in multiple sclerosis trials","volume":"5","author":"Barkhof","year":"2009","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.ophtha.2011.11.032_bib10","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1093\/brain\/awq346","article-title":"Primary retinal pathology in multiple sclerosis as detected by optical coherence tomography","volume":"134","author":"Saidha","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.ophtha.2011.11.032_bib11","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1097\/WNO.0b013e318221b434","article-title":"Retinal ganglion cell layer volumetric assessment by spectral-domain optical coherence tomography in multiple sclerosis: application of a high-precision manual estimation technique","volume":"31","author":"Davies","year":"2011","journal-title":"J Neuroophthalmol"},{"key":"10.1016\/j.ophtha.2011.11.032_bib12","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.ophtha.2005.10.040","article-title":"Relation of visual function to retinal nerve fiber layer thickness in multiple sclerosis","volume":"113","author":"Fisher","year":"2006","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2011.11.032_bib13","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1002\/ana.22005","article-title":"Longitudinal study of vision and retinal nerve fiber layer thickness in multiple sclerosis","volume":"67","author":"Talman","year":"2010","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ophtha.2011.11.032_bib14","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1111\/j.1755-3768.2009.01527.x","article-title":"Sub-clinical atrophy of the retinal nerve fibre layer in multiple sclerosis","volume":"88","author":"Pueyo","year":"2010","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.ophtha.2011.11.032_bib15","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1177\/112067211002000122","article-title":"Retinal nerve fiber layer thickness and spatial and temporal contrast sensitivity in multiple sclerosis","volume":"20","author":"Merle","year":"2010","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.ophtha.2011.11.032_bib16","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1001\/archneurol.2009.230","article-title":"Macular volume determined by optical coherence tomography as a measure of neuronal loss in multiple sclerosis","volume":"66","author":"Burkholder","year":"2009","journal-title":"Arch Neurol"},{"key":"10.1016\/j.ophtha.2011.11.032_bib17","first-page":"277","article-title":"An investigation of the retinal nerve fibre layer in progressive multiple sclerosis using optical coherence tomography","volume":"131","author":"Henderson","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.ophtha.2011.11.032_bib18","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1177\/1352458508100503","article-title":"Retinal architecture predicts pupillary reflex metrics in MS","volume":"15","author":"Salter","year":"2009","journal-title":"Mult Scler"},{"key":"10.1016\/j.ophtha.2011.11.032_bib19","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/ana.21436","article-title":"Gray matter atrophy in multiple sclerosis: a longitudinal study","volume":"64","author":"Fisher","year":"2008","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ophtha.2011.11.032_bib20","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/ana.21423","article-title":"Gray matter atrophy is related to long-term disability in multiple sclerosis","volume":"64","author":"Fisniku","year":"2008","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ophtha.2011.11.032_bib21","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.jns.2009.01.012","article-title":"Grey matter pathology in clinically early multiple sclerosis: evidence from magnetic resonance imaging","volume":"282","author":"Chard","year":"2009","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.ophtha.2011.11.032_bib22","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1016\/j.neuroimage.2009.09.005","article-title":"A topology-preserving approach to the segmentation of brain images with multiple sclerosis lesions","volume":"49","author":"Shiee","year":"2010","journal-title":"NeuroImage"},{"key":"10.1016\/j.ophtha.2011.11.032_bib23","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1212\/WNL.0b013e3181ff96f6","article-title":"Intracortical lesions: relevance for new MRI diagnostic criteria for multiple sclerosis","volume":"75","author":"Filippi","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.ophtha.2011.11.032_bib24","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1001\/archneurol.2010.148","article-title":"Imaging cortical lesions in multiple sclerosis with ultra-high-field magnetic resonance imaging","volume":"67","author":"Pitt","year":"2010","journal-title":"Arch Neurol"},{"key":"10.1016\/j.ophtha.2011.11.032_bib25","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.ophtha.2007.08.011","article-title":"Mapping of macular substructures with optical coherence tomography for glaucoma diagnosis","volume":"115","author":"Tan","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2011.11.032_bib26","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1016\/j.ophtha.2009.05.025","article-title":"Detection of macular ganglion cell loss in glaucoma by Fourier-domain optical coherence tomography","volume":"116","author":"Tan","year":"2009","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2011.11.032_bib27","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1167\/iovs.04-0335","article-title":"Macular segmentation with optical coherence tomography","volume":"46","author":"Ishikawa","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2011.11.032_bib28","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/ana.1032","article-title":"Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis","volume":"50","author":"McDonald","year":"2001","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ophtha.2011.11.032_bib29","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1177\/135245850000600305","article-title":"New low-contrast vision charts: reliability and test characteristics in patients with multiple sclerosis","volume":"6","author":"Balcer","year":"2000","journal-title":"Mult Scler"},{"key":"10.1016\/j.ophtha.2011.11.032_bib30","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1212\/01.wnl.0000259521.14704.a8","article-title":"Natalizumab reduces visual loss in patients with relapsing multiple sclerosis","volume":"68","author":"Balcer","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.ophtha.2011.11.032_bib31","doi-asserted-by":"crossref","first-page":"3278","DOI":"10.1167\/iovs.02-1100","article-title":"How sensitive to clinical change are ETDRS logMAR visual acuity measurements?","volume":"44","author":"Rosser","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2011.11.032_bib32","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1016\/j.ophtha.2007.06.047","article-title":"Visual acuity as an outcome measure in clinical trials of retinal diseases","volume":"114","author":"Beck","year":"2007","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2011.11.032_bib33","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1001\/archopht.119.7.1050","article-title":"Development of the 25-item National Eye Institute Visual Function Questionnaire","volume":"119","author":"Mangione","year":"2001","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2011.11.032_bib34","first-page":"1017","article-title":"The National Eye Institute Visual Function Questionnaire: experience of the ONTT","volume":"41","author":"Cole","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2011.11.032_bib35","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.ajo.2006.06.060","article-title":"Validation and test characteristics of a 10-item neuro-ophthalmic supplement to the NEI-VFQ-25","volume":"142","author":"Raphael","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2011.11.032_bib36","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1136\/jnnp.2008.165449","article-title":"Vision related quality of life in multiple sclerosis: correlation with new measures of low and high contrast letter acuity","volume":"80","author":"Mowry","year":"2009","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.ophtha.2011.11.032_bib37","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.ophtha.2004.02.003","article-title":"The impact of visual impairment on self-reported visual functioning in Latinos: the Los Angeles Latino Eye Study","volume":"111","author":"Globe","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2011.11.032_bib38","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1080\/09286580701502970","article-title":"Evaluation of minimum clinically meaningful changes in scores on the National Eye Institute Visual Function Questionnaire (NEI-VFQ): SST report number 19","volume":"14","year":"2007","journal-title":"Ophthalmic Epidemiol"},{"key":"10.1016\/j.ophtha.2011.11.032_bib39","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.ophtha.2009.01.004","article-title":"Effects of age on optical coherence tomography measurements of healthy retinal nerve fiber layer, macula, and optic nerve head","volume":"116","author":"Sung","year":"2009","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2011.11.032_bib40","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1093\/brain\/awq080","article-title":"Ocular pathology in multiple sclerosis: retinal atrophy and inflammation irrespective of disease duration","volume":"133","author":"Green","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.ophtha.2011.11.032_bib41","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s11910-009-0060-3","article-title":"Axonal degeneration in multiple sclerosis: the mitochondrial hypothesis","volume":"9","author":"Su","year":"2009","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10.1016\/j.ophtha.2011.11.032_bib42","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1471-4159.2011.07182.x","article-title":"Decreased activity of the 20S proteasome in the brain white matter and gray matter of patients with multiple sclerosis","volume":"117","author":"Zheng","year":"2011","journal-title":"J Neurochem"},{"key":"10.1016\/j.ophtha.2011.11.032_bib43","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/eye.2010.218","article-title":"Outer retinal abnormalities associated with inner retinal pathology in nonglaucomatous and glaucomatous optic neuropathies","volume":"25","author":"Werner","year":"2011","journal-title":"Eye"},{"key":"10.1016\/j.ophtha.2011.11.032_bib44","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1177\/1352458511418630","article-title":"Visual dysfunction in multiple sclerosis correlates better with optical coherence tomography derived estimates of macular ganglion cell thickness than peripapillary retinal nerve fiber layer thickness","volume":"17","author":"Saidha","year":"2011","journal-title":"Mult Scler"},{"key":"10.1016\/j.ophtha.2011.11.032_bib45","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1097\/WNO.0b013e3181f7f833","article-title":"Oral resveratrol reduces neuronal damage in a model of multiple sclerosis","volume":"30","author":"Shindler","year":"2010","journal-title":"J Neuroophthalmol"},{"key":"10.1016\/j.ophtha.2011.11.032_bib46","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/ana.22247","article-title":"Axonal damage in relapsing multiple sclerosis is markedly reduced by natalizumab","volume":"69","author":"Gunnarsson","year":"2011","journal-title":"Ann Neurol"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642011011353?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642011011353?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T14:01:45Z","timestamp":1758981705000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642011011353"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":46,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S0161642011011353"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2011.11.032","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ganglion Cell Loss in Relation to Visual Disability in Multiple Sclerosis","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ophtha.2011.11.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}